Evidence map›Paper›PMID 33340644›Full record

ArticleRegulatory toxicology and pharmacology : RTP2021

A cross-industry collaboration to assess if acute oral toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling.

Joel Bercu, Melisa J Masuda-Herrera, Alejandra Trejo-Martin, Catrin Hasselgren, Jean Lord, Jessica Graham, Matthew Schmitz, Lawrence Milchak, Colin Owens, Surya Hari Lal and 12 more

Erratum issuedAbstract read
In one paragraph

Article in Regulatory toxicology and pharmacology : RTP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Principles and Procedures for Assessment of Acute Toxicity IncorporatingComputational toxicology (Amsterdam, Netherlands) · 2022
    Article
  6. Evaluation of Variability Across Rat Acute Oral Systemic Toxicity Studies.Toxicological sciences : an official journal of the Society of Toxicology · 2022
    Article
  7. Article
  8. In Silico Models for Predicting Acute Systemic Toxicity.Methods in molecular biology (Clifton, N.J.) · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Joel BercuGilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.
Melisa J Masuda-HerreraGilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.
Alejandra Trejo-MartinGilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.
Catrin HasselgrenGenentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Jean LordUltragenyx, 60 Leveroni Court, Novato, CA, 94949, USA.
Jessica GrahamBristol Myers Squibb, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.
Matthew SchmitzAbbVie Inc., North Chicago, IL, USA.
Lawrence Milchak3M Company, 3M Center, St. Paul, MN, 55144-1000, USA.
Colin Owens3M Company, 3M Center, St. Paul, MN, 55144-1000, USA.
Surya Hari LalSyngenta Crop Protection, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK(1).
Richard Marchese RobinsonSyngenta Crop Protection, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK(1).
Sarah WhalleySyngenta Crop Protection, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK(1).
Phillip BellionDSM Nutritional Products, Kaiseraugst, Switzerland.
Anna VuorinenDSM Nutritional Products, Kaiseraugst, Switzerland.
Kamila GromekGalapagos SASU, 102 Avenue Gaston Roussel, 93230, Romainville, France.
William A HawkinsGlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.
Iris van de GevelJanssen Pharmaceutical Companies of Johnson & Johnson, 2340, Beerse, Belgium.
Kathleen VriensJanssen Pharmaceutical Companies of Johnson & Johnson, 2340, Beerse, Belgium.
Raymond KemperVertex Pharmaceuticals Inc., Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, USA.
Russell NavenVertex Pharmaceuticals Inc., Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, USA.
Pierre FerrerDepartment of Veterinary Physiology and Pharmacology, Interdisciplinary Faculty of Toxicology Program, Texas A&M University, 4466 TAMU, College Station, TX, 77843-4466, USA.
Glenn J MyattLeadscope (an Instem company), 1393 Dublin Rd, Columbus, OH, 43215, USA. Electronic address: gmyatt@leadscope.com.

Funding

Regulatory Science in Environmental Health and ToxicologyT32ES026568 · NIEHS · TEXAS A&M UNIVERSITY · PI Weihsueh A Chiu, Natalie M Johnson · 2016 to 2026
$3.8M
Rapid response toxicology prediction platformR44ES026909 · NIEHS · LEADSCOPE, INC. · PI MYATT, GLENN JOHN · 2018 to 2019
$1000k
NIEHS NIH HHS R44 ES026909NIEHS NIH HHS T32 ES026568
6 · The paper itself

Abstract

This study assesses whether currently available acute oral toxicity (AOT) in silico models, provided by the widely employed Leadscope software, are fit-for-purpose for categorization and labelling of chemicals. As part of this study, a large data set of proprietary and marketed compounds from multiple companies (pharmaceutical, plant protection products, and other chemical industries) was assembled to assess the models' performance. The absolute percentage of correct or more conservative predictions, based on a comparison of experimental and predicted GHS categories, was approximately 95%, after excluding a small percentage of inconclusive (indeterminate or out of domain) predictions. Since the frequency distribution across the experimental categories is skewed towards low toxicity chemicals, a balanced assessment was also performed. Across all compounds which could be assigned to a well-defined experimental category, the average percentage of correct or more conservative predictions was around 80%. These results indicate the potential for reliable and broad application of these models across different industrial sectors. This manuscript describes the evaluation of these models, highlights the importance of an expert review, and provides guidance on the use of AOT models to fulfill testing requirements, GHS classification/labelling, and transportation needs.

Indexed as

Computer SimulationIntersectoral CollaborationQuantitative Structure-Activity RelationshipAdministration, OralAnimalsAnimal Testing AlternativesChemical IndustryCytotoxinsDatabases, FactualDrug IndustryHumansProduct LabelingCytotoxinsAcute oral Toxicity (Q)SARClassification and labellingCLP/GHS GHSExpert rule-based Statistical-based modelIn silico 3Rs Expert review

Identifiers

PMID33340644
PMCPMC8005249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.